Gemina Laboratories Balance Sheet

Financials in millions CAD. Fiscal year is February - January.

Millions CAD. Fiscal year is Feb - Jan.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '24 Oct 31, 2024	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022	Jan '21 Jan 31, 2021
Cash & Equivalents	0.04	0	0.08	1.16	0.88
Cash & Short-Term Investments	0.04	0	0.08	1.16	0.88
Cash Growth	1336.38%	-98.81%	-92.81%	31.12%	-
Accounts Receivable	-	-	-	0.01	0.02
Other Receivables	0.01	0.04	0.39	0.18	0
Receivables	0.01	0.04	0.39	0.19	0.02
Prepaid Expenses	0.11	0.05	0.09	0.03	0.01
Restricted Cash	-	-	-	-	1.54
Total Current Assets	0.17	0.09	0.56	1.38	2.45
Property, Plant & Equipment	0.35	0.37	0.32	0.04	0.05
Long-Term Investments	1.02	0.99	0.99	-	-
Long-Term Accounts Receivable	-	-	-	-	0.01
Other Long-Term Assets	-	-	-	-	0.02
Total Assets	1.53	1.46	1.87	1.42	2.53
Accounts Payable	2.51	1.67	0.93	0.33	0.08
Accrued Expenses	1.02	0.89	0.78	0.1	0.04
Short-Term Debt	1.16	0.2	-	-	-
Current Portion of Leases	0.1	0.08	0.04	0.04	0.06
Other Current Liabilities	-	-	-	-	2.15
Total Current Liabilities	4.79	2.84	1.75	0.47	2.33
Long-Term Leases	0.2	0.21	0.2	0.01	0.04
Total Liabilities	4.99	3.04	1.95	0.48	2.37
Common Stock	12.09	11.24	8.15	5.62	0.99
Retained Earnings	-19.42	-16.76	-11.55	-5.57	-0.83
Comprehensive Income & Other	3.87	3.94	3.33	0.89	-
Shareholders' Equity	-3.46	-1.59	-0.07	0.94	0.16
Total Liabilities & Equity	1.53	1.46	1.87	1.42	2.53
Total Debt	1.46	0.49	0.24	0.05	0.1
Net Cash (Debt)	-1.42	-0.48	-0.16	1.11	0.78
Net Cash Growth	-	-	-	41.65%	-
Net Cash Per Share	-0.02	-0.01	-0.00	0.02	0.02
Filing Date Shares Outstanding	74.57	73.33	73.33	55.6	38.47
Total Common Shares Outstanding	74.57	73.33	65.85	55.6	38.47
Working Capital	-4.62	-2.74	-1.19	0.91	0.12
Book Value Per Share	-0.05	-0.02	-0.00	0.02	0.00
Tangible Book Value	-3.46	-1.59	-0.07	0.94	0.16
Tangible Book Value Per Share	-0.05	-0.02	-0.00	0.02	0.00
Machinery	0.08	0.08	0.06	0.01	-
Leasehold Improvements	-	0.05	0.03	0.02	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.